Literature DB >> 26835177

Long-Term Neurodevelopmental Outcomes in Children and Adolescents With Congenital Heart Disease.

Jeanette M Jerrell1, C Osborne Shuler1, Avnish Tripathi2, George B Black3, Yong-Moon Mark Park4.   

Abstract

BACKGROUND: Effective medical and surgical management of pediatric congenital heart disease (CHD) to reduce long-term adverse neurodevelopmental outcomes is an important clinical objective in primary and specialty health care. We identify clinical predictors associated with an increased risk of 6 long-term neurodevelopmental outcomes in children with CHD compared to the general pediatric Medicaid population.
METHOD: South Carolina's retrospective, 15-year Medicaid data set (January 1, 1996-December 31, 2010) for 19,947 patients aged ≤ 17 years diagnosed with ≥ 1 CHD lesions (on the basis of International Classification of Diseases, Ninth Revision, Clinical Modification codes) were compared to 19,948 patients without CHD matched on age at entry into and duration in Medicaid using logistic and Cox proportional hazards regression.
RESULTS: The CHD cohort was significantly less likely to have incident neurologic or psychiatric disorders, mental retardation, developmental delays, or inattention/hyperactivity (adjusted odds ratios [ORs] = 0.34, 0.56, 0.03, 0.01, 0.004, respectively) but was more likely to have incident seizures (OR = 2.00) compared to controls. Exposure to both cardiac and noncardiac surgical intervention was associated with a significantly increased risk of developing neurologic or psychiatric disorders, mental retardation, developmental delays, or inattention/hyperactivity (cardiac ORs = 1.66, 2.00, 1.67, 1.43, 1.76, respectively) (noncardiac ORs = 2.25, 1.59, 1.48, 1.29, 1.36, 2.46, respectively). Any documented hypoxemia was associated with a significantly increased risk of developing 5 of the neurodevelopmental conditions (neurologic OR = 4.52, psychiatric OR = 1.60, mental retardation OR = 2.90, developmental delay OR = 2.12, seizures OR = 4.23).
CONCLUSION: Practitioners should maintain vigilant surveillance of all CHD patients, especially those exposed to surgical procedures or experiencing hypoxemia, to identify any neurodevelopmental issues early and address them promptly.

Entities:  

Year:  2015        PMID: 26835177      PMCID: PMC4732321          DOI: 10.4088/PCC.15m01842

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN: 2155-7780


  25 in total

1.  Factors associated with the occurrence and treatment of supraventricular tachycardia in a pediatric congenital heart disease cohort.

Authors:  Avnish Tripathi; George B Black; Yong-Moon Mark Park; Jeanette M Jerrell
Journal:  Pediatr Cardiol       Date:  2013-09-01       Impact factor: 1.655

Review 2.  Utilization of health care databases for pharmacoepidemiology.

Authors:  Yasuo Takahashi; Yayoi Nishida; Satoshi Asai
Journal:  Eur J Clin Pharmacol       Date:  2011-08-02       Impact factor: 2.953

3.  Racial and temporal variations in the prevalence of heart defects.

Authors:  L D Botto; A Correa; J D Erickson
Journal:  Pediatrics       Date:  2001-03       Impact factor: 7.124

4.  Population-based treated prevalence of congenital heart disease in a pediatric cohort.

Authors:  C Osborne Shuler; George B Black; Jeanette M Jerrell
Journal:  Pediatr Cardiol       Date:  2012-09-14       Impact factor: 1.655

5.  Attentional dysfunction in children after corrective cardiac surgery in infancy.

Authors:  Hedwig H Hövels-Gürich; Kerstin Konrad; Daniela Skorzenski; Beate Herpertz-Dahlmann; Bruno J Messmer; Marie-Christine Seghaye
Journal:  Ann Thorac Surg       Date:  2007-04       Impact factor: 4.330

6.  Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital heart disease.

Authors:  Amanda J Shillingford; Marianne M Glanzman; Richard F Ittenbach; Robert R Clancy; J William Gaynor; Gil Wernovsky
Journal:  Pediatrics       Date:  2008-04       Impact factor: 7.124

7.  Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data.

Authors:  Sean Hennessy; Charles E Leonard; Cristin P Freeman; Rajat Deo; Craig Newcomb; Stephen E Kimmel; Brian L Strom; Warren B Bilker
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-06       Impact factor: 2.890

8.  Prevalence and management of patent ductus arteriosus in a pediatric medicaid cohort.

Authors:  Avnish Tripathi; George B Black; Yong-Moon Mark Park; Jeanette M Jerrell
Journal:  Clin Cardiol       Date:  2013-05-29       Impact factor: 2.882

Review 9.  Factors associated with adverse neurodevelopmental outcomes in infants with congenital heart disease.

Authors:  An N Massaro; Mohamed El-Dib; Penny Glass; Hany Aly
Journal:  Brain Dev       Date:  2008-02-04       Impact factor: 1.961

10.  Neurodevelopmental outcomes following two different treatment approaches (early ligation and selective ligation) for patent ductus arteriosus.

Authors:  Andrea C Wickremasinghe; Elizabeth E Rogers; Robert E Piecuch; Bridget C Johnson; Suzanne Golden; Anita J Moon-Grady; Ronald I Clyman
Journal:  J Pediatr       Date:  2012-07-13       Impact factor: 4.406

View more
  1 in total

1.  Association of Cerebrovascular Stability Index and Head Circumference Between Infants With and Without Congenital Heart Disease.

Authors:  Nhu N Tran; Michelle Tran; Ashok Panigrahy; Ken M Brady; Jodie K Votava-Smith
Journal:  Pediatr Cardiol       Date:  2022-04-15       Impact factor: 1.838

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.